Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Clinician,Neoadjuvant nivolumab in combination with ipilimumab,for the treatment of resectable cutaneous melanoma (Stage III),Neoadjuvant nivolumab in combination with ipilimumab (Opdivo Yervoy),Options for investment,Hospital,Oncology Agents and Immunosuppressants
